Batchuluun, Battsetseg
Pinkosky, Stephen L.
Steinberg, Gregory R. http://orcid.org/0000-0001-5425-8275
Article History
Accepted: 3 November 2021
First Online: 14 January 2022
Competing interests
: G.R.S. has received research funding from Esperion Therapeutics, Espervita Therapeutics, Poxel Pharmaceuticals and Novo Nordisk, honoraria and/or consulting fees from Astra Zeneca, Eli-Lilly, Esperion Therapeutics, Poxel Pharmaceuticals, Merck and is a founder and shareholder of Espervita Therapeutics. S.L.P. is employed by Esperion Therapeutics and is a shareholder. B.B. declares no competing interests.
Free to read: This content has been made available to all.